Chiesi Ltd., a subsidiary of the Chiesi Group, is a prominent player in the global pharmaceutical industry, headquartered in Great Britain. Founded in 1935, the company has established itself as a leader in the development of innovative therapies, particularly in the fields of respiratory, neonatology, and rare diseases. With a strong presence across Europe and expanding operations in other regions, Chiesi Ltd. is committed to improving patient outcomes through its unique portfolio of products. The company is renowned for its cutting-edge inhalation therapies and advanced drug delivery systems, which set it apart in a competitive market. Chiesi Ltd. has achieved significant milestones, including recognition for its sustainable practices and commitment to research and development. As a result, it holds a notable position within the pharmaceutical sector, dedicated to enhancing the quality of life for patients worldwide.
We don't have data for Chiesi Ltd., but we can show you information about their parent organization instead.
View parent company